Efficacies of Moxifloxacin, Ciprofloxacin, and Vancomycin against Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus Expressing Various Degrees of Ciprofloxacin Resistance

The new 8-methoxyquinolone moxifloxacin was tested against two ciprofloxacin-susceptible Staphylococcus aureus strains (strains P8 and COL) and two ciprofloxacin-resistant derivatives of strain P8 carrying a single grlA mutation (strain P8-4) and double grlA and gyrA mutations (strain P8-128). All s...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Entenza, J. M., Que, Y. A., Vouillamoz, J., Glauser, M. P., Moreillon, P.
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 2001
Soggetti:	Experimental Therapeutics
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90785/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11600359/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.11.3076-3083.2001
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!